The trial is to show efficiency, eIND show amazing results how would that only be 30% chance? I think you're way off. I put it at 95% chance of approval. And as far as manufacturing, the day they get that approval it's now a multi billion dollar winning lottery ticket. They will have multiple deals for manu. I'm almost sure they already have multiple in place right now that we don't even know about.
CYDY insiders (CEO, CFO and Directors) stuffing their pockets NOW (see filings) while the next tout is being prepped for release-
Other Possibilities
There is, for example, interest in a 400-patient trial of leronlimab for Alzheimer's. I heard talk of the blood brain barrier, but I do not understand the method of action here. Presumably, cytokines and chemokines may be creating mischief in the brain - inflammation, but without further explanation, I would not make this my reason to buy CYDY.